Matheis Dennis (CIK 1817012) reported 12 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-28). Recent activity: Buy DRIO (965 shares), Buy DRIO (14,430 shares), Buy LUCD (245,000 shares), Buy LUCD (123,000 shares), Buy DRIO (20,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-28 | DarioHealth Corp. (DRIO) | Director | Buy | 965 | $18,432 |
| 2026-07-28 | DarioHealth Corp. (DRIO) | Director | Buy | 14,430 | $100,000 |
| 2026-05-21 | Lucid Diagnostics Inc. (LUCD) | Director | Buy | 245,000 | $245,270 |
| 2026-02-24 | Lucid Diagnostics Inc. (LUCD) | Director | Buy | 123,000 | $0 |
| 2025-09-15 | DarioHealth Corp. (DRIO) | Director | Buy | 20,000 | $0 |
| 2025-08-22 | Lucid Diagnostics Inc. (LUCD) | Director | Buy | 100,000 | $102,000 |
| 2025-05-23 | Lucid Diagnostics Inc. (LUCD) | Director | Buy | 187,098 | $243,227 |
| 2025-05-23 | Lucid Diagnostics Inc. (LUCD) | Director | Buy | 129,684 | $171,183 |
| 2025-05-23 | Lucid Diagnostics Inc. (LUCD) | Director | Buy | 33,218 | $43,848 |
| 2025-05-22 | Lucid Diagnostics Inc. (LUCD) | Director | Buy | 187,098 | $243,227 |
| 2025-05-22 | Lucid Diagnostics Inc. (LUCD) | Director | Buy | 129,684 | $171,183 |
| 2025-05-22 | Lucid Diagnostics Inc. (LUCD) | Director | Buy | 33,218 | $43,848 |
Source: SEC Form 4 filings · as of 2026-07-28